{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:10:21Z","timestamp":1787771421364,"version":"build-2784847793"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-025-02410-6","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T03:51:32Z","timestamp":1757389892000},"page":"2871-2879","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["An observational study on mesangial C4d staining as a prognostic tool in IgA nephropathy"],"prefix":"10.1093","volume":"38","author":[{"given":"Srinidhi","family":"Viswanathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayalakshmi","family":"Seshadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anila Abraham","family":"Kurien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrini Devi","family":"Palani Baskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prem Kumar","family":"Devaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prathiba","family":"Parthasarathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveenkumar","family":"Natarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumathi","family":"Govindaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopikumar","family":"Sekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakthirajan","family":"Ramanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dineshkumar","family":"Thanigachalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheik Sulthan","family":"Alavudeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivakumar","family":"Dakshinamoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seenivasan","family":"Mookaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8813-764X","authenticated-orcid":false,"given":"Gopalakrishnan","family":"Natarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,9]]},"reference":[{"issue":"1","key":"2410_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-023-00476-9","volume":"9","author":"E Stamellou","year":"2023","unstructured":"Stamellou E, Seikrit C, Tang SCW (2023) IgA nephropathy. Nat Rev Dis Primers 9(1):1\u201321","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"2410_CR2","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00467-017-3699-z","volume":"33","author":"SC Yeo","year":"2017","unstructured":"Yeo SC, Cheung CK, Barratt J (2017) New insights into the pathogenesis of IgA nephropathy. Pediatric Nephrol 33(5):763\u2013777","journal-title":"Pediatric Nephrol"},{"issue":"7","key":"2410_CR3","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s00467-016-3575-2","volume":"32","author":"R Copp","year":"2017","unstructured":"Copp R (2017) C4d deposits in IgA nephropathy: where does complement activation come from? Pediatr Nephrol 32(7):1097\u20131101","journal-title":"Pediatr Nephrol"},{"issue":"7","key":"2410_CR4","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1681\/ASN.2014101000","volume":"26","author":"N Maillard","year":"2015","unstructured":"Maillard N, Wyatt RJ, Julian BA (2015) Current understanding of the role of complement in IGA nephropathy. J Am Soc Nephrol 26(7):1503\u20131512","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"2410_CR5","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/ki.2011.497","volume":"81","author":"D Cohen","year":"2012","unstructured":"Cohen D, Colvin RB, Daha MR (2012) Pros and cons for C4d as a biomarker. Kidney Int 81(7):628\u2013639","journal-title":"Kidney Int"},{"issue":"2","key":"2410_CR6","doi-asserted-by":"publisher","first-page":"258","DOI":"10.2215\/CJN.02530317","volume":"13","author":"A Segarra","year":"2017","unstructured":"Segarra A, Romero K, Agraz I (2017) Mesangial C4D deposits in early IGA nephropathy. Clin J Am Soc Nephrol 13(2):258\u2013264","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"2410_CR7","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s00467-017-3610-y","volume":"32","author":"RCG Fabiano","year":"2017","unstructured":"Fabiano RCG, De Almeida Ara\u00fajo S, Bambirra EA (2017) Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy. Pediatric Nephrol 32(7):1211\u20131220","journal-title":"Pediatric Nephrol"},{"issue":"4","key":"2410_CR8","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1681\/ASN.2010040355","volume":"22","author":"F Berthoux","year":"2011","unstructured":"Berthoux F, Mohey H, Laurent B (2011) Predicting the risk for dialysis or death in IGA nephropathy. J Am Soc Nephrol 22(4):752\u2013761","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"2410_CR9","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1681\/ASN.2018101017","volume":"30","author":"S Jarrick","year":"2019","unstructured":"Jarrick S, Lundberg S, Welander A (2019) Mortality in IGA nephropathy: a nationwide population-based cohort study. J Am Soc Nephrol 30(5):866\u2013876","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2410_CR10","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1093\/ndt\/gfr527","volume":"27","author":"W Le","year":"2011","unstructured":"Le W, Liang S, Hu Y (2011) Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population. Nephrol Dial Transplant 27(4):1479\u20131485","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"2410_CR11","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1681\/ASN.2007050526","volume":"18","author":"HN Reich","year":"2007","unstructured":"Reich HN, Troyanov S, Scholey JW (2007) Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol 18(12):3177\u20133183","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"2410_CR12","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1053\/j.ajkd.2016.02.042","volume":"68","author":"LA Inker","year":"2016","unstructured":"Inker LA, Mondal H, Greene T (2016) Early change in urine protein as a surrogate end point in studies of IgA nephropathy: an individual-patient meta-analysis. Am J Kidney Dis 68(3):392\u2013401","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"2410_CR13","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.kint.2017.02.003","volume":"91","author":"H Trimarchi","year":"2017","unstructured":"Trimarchi H, Barratt J, Cattran DC (2017) Oxford classification of IgA nephropathy 2016: an update from the IgA nephropathy classification working group. Kidney Int 91(5):1014\u20131021","journal-title":"Kidney Int"},{"issue":"10","key":"2410_CR14","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1681\/ASN.2011050464","volume":"22","author":"H Suzuki","year":"2011","unstructured":"Suzuki H, Kiryluk K, Novak J (2011) The pathophysiology of IgA nephropathy. J Am Soc Nephrol 22(10):1795\u20131803","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"2410_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1053\/j.ackd.2019.12.004","volume":"27","author":"NR Medjeral-Thomas","year":"2020","unstructured":"Medjeral-Thomas NR, O\u2019Shaughnessy MM (2020) Complement in IGA nephropathy: the role of complement in the pathogenesis, diagnosis, and future management of IGA nephropathy. Adv Chronic Kidney Dis 27(2):111\u2013119","journal-title":"Adv Chronic Kidney Dis"},{"issue":"9","key":"2410_CR16","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/ni.1923","volume":"11","author":"D Ricklin","year":"2010","unstructured":"Ricklin D, Hajishengallis G, Yang K (2010) Complement: a key system for immune surveillance and homeostasis. Nat Immunol 11(9):785\u2013797","journal-title":"Nat Immunol"},{"issue":"1","key":"2410_CR17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.4103\/kleuhsj.kleuhsj_156_18","volume":"12","author":"A Singhai","year":"2019","unstructured":"Singhai A, Yadav S, Babu S et al (2019) Utility of C4D deposits in native renal diseases and relation with disease progression. Indian J Health Sci Biomed Res (KLEU) 12(1):50. https:\/\/doi.org\/10.4103\/kleuhsj.kleuhsj_156_18","journal-title":"Indian J Health Sci Biomed Res (KLEU)"},{"issue":"6","key":"2410_CR18","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.xkme.2021.06.009","volume":"3","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Zan J, Shi S (2021) Glomerular C4D deposition and kidney disease progression in IGA nephropathy: a systematic review and meta-analysis. Kidney Med 3(6):1014\u20131021","journal-title":"Kidney Med"},{"issue":"9","key":"2410_CR19","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.3109\/0886022X.2015.1077319","volume":"37","author":"C Heybeli","year":"2015","unstructured":"Heybeli C, Unlu M, Yildiz S (2015) IgA nephropathy: association of C4d with clinical and histopathological findings and possible role of IgM. Ren Fail 37(9):1464\u20131466","journal-title":"Ren Fail"},{"issue":"6","key":"2410_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252638","volume":"16","author":"S Worawichawong","year":"2021","unstructured":"Worawichawong S, Plumworasawat S, Liwlompaisan W (2021) Distribution pattern of mesangial C4d deposits as predictor of kidney failure in IgA nephropathy. PLoS\u00a0One 16(6):e0252638","journal-title":"PLoS\u00a0One"},{"issue":"17","key":"2410_CR21","doi-asserted-by":"publisher","first-page":"5338","DOI":"10.3390\/jcm13175338","volume":"13","author":"N Zagorec","year":"2024","unstructured":"Zagorec N, Horvati\u0107 I, Kasumovi\u0107 D, Osmani B, Sovi\u0107 S, Niki\u0107 J, Hora\u010dek M, \u0160enjug P, Gale\u0161i\u0107 K, Gale\u0161i\u0107 LD (2024) C4d is an independent predictor of the kidney failure in primary IgA nephropathy. J Clin Med 13(17):5338. https:\/\/doi.org\/10.3390\/jcm13175338","journal-title":"J Clin Med"},{"issue":"6","key":"2410_CR22","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1681\/ASN.2005090923","volume":"17","author":"A Roos","year":"2006","unstructured":"Roos A, Rastaldi MP, Calvaresi N (2006) Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol 17(6):1724\u20131734","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"2410_CR23","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.kint.2023.04.029","volume":"104","author":"J Barratt","year":"2023","unstructured":"Barratt J, Lafayette RA, Zhang H (2023) IgA nephropathy: the lectin pathway and implications for targeted therapy. Kidney Int 104(2):254\u2013264","journal-title":"Kidney Int"},{"issue":"5","key":"2410_CR24","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1053\/j.ajkd.2020.03.017","volume":"76","author":"B Faria","year":"2020","unstructured":"Faria B, Can\u00e3o P, Cai Q (2020) Arteriolar C4d in IgA nephropathy: a cohort study. Am J Kidney Dis 76(5):669\u2013678","journal-title":"Am J Kidney Dis"},{"key":"2410_CR25","unstructured":"Bose BM, Pothen L and Parameswaran JK (2016) Clinicopathological comparative study of C4d positive and negative cases of IgA nephropathy. https:\/\/immunopathol.com\/Article\/ipp-33"},{"issue":"4","key":"2410_CR26","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s00467-022-05725-9","volume":"38","author":"W Zhou","year":"2023","unstructured":"Zhou W, Wang H, Sun S (2023) Association between glomerular C4d deposition, proteinuria, and disease severity in children with IgA nephropathy. Pediatr Nephrol 38(4):1147\u20131157","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"2410_CR27","first-page":"19","volume":"4","author":"H Nasri","year":"2015","unstructured":"Nasri H, Ahmadi A, Rafieian-Kopaei M (2015) Association of glomerular C4d deposition with various demographic data in IgA nephropathy patients; a preliminary study. PubMed 4(1):19\u201323","journal-title":"PubMed"},{"issue":"6","key":"2410_CR28","first-page":"3299","volume":"7","author":"OZ Sahin","year":"2014","unstructured":"Sahin OZ, Yavas H, Tasli F (2014) Prognostic value of glomerular C4d staining in patients with IgA nephritis. Int J Clin Exp Pathol 7(6):3299\u20133304","journal-title":"Int J Clin Exp Pathol"},{"key":"2410_CR29","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.clim.2019.108331","volume":"211","author":"KH Nam","year":"2020","unstructured":"Nam KH, Joo YS, Lee C (2020) Predictive value of mesangial C3 and C4d deposition in IgA nephropathy. Clin Immunol 211:108\u2013331","journal-title":"Clin Immunol"},{"issue":"1","key":"2410_CR30","first-page":"137","volume":"81","author":"W Zhang","year":"1994","unstructured":"Zhang W, Lachmann PJ (1994) Glycosylation of IgA is required for optimal activation of the alternative complement pathway by immune complexes. Immunology 81(1):137\u2013141","journal-title":"Immunology"},{"issue":"5","key":"2410_CR31","doi-asserted-by":"publisher","first-page":"897","DOI":"10.2215\/CJN.09710913","volume":"9","author":"M Espinosa","year":"2014","unstructured":"Espinosa M, Ortega R, S\u00e1nchez M (2014) Association of C4d deposition with clinical outcomes in IgA nephropathy. Clin J Am Soc Nephrol 9(5):897\u2013904","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"2410_CR32","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1016\/j.ekir.2023.06.010","volume":"8","author":"V Tesa\u0159","year":"2023","unstructured":"Tesa\u0159 V, Radhakrishnan J, Charu V, Barratt J (2023) Challenges in IGA nephropathy management: an era of complement inhibition. Kidney Int Rep 8(9):1730\u20131740. https:\/\/doi.org\/10.1016\/j.ekir.2023.06.010","journal-title":"Kidney Int Rep"},{"key":"2410_CR33","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2410316","author":"V Perkovic","year":"2025","unstructured":"Perkovic V, Barratt J, Rovin B (2025) Alternative complement pathway inhibition with Iptacopan in IgA nephropathy. N Engl J Med. https:\/\/doi.org\/10.1056\/nejmoa2410316","journal-title":"N Engl J Med"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-025-02410-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-025-02410-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-025-02410-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:59:47Z","timestamp":1777564787000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/38\/9\/2871\/8462677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,9]]},"references-count":33,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2410"],"URL":"https:\/\/doi.org\/10.1007\/s40620-025-02410-6","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,9]]},"assertion":[{"value":"25 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approval was obtained from the Ethics Committee of Madras Medical College (IEC\/MMC\/21032024).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent to participate"}}]}}